Mixed Test Results For AVI BioPharma
Mixed results from AVI BioPharma Inc.'s (AVII) hepatitis C treatment AVI-4065 sent shares of the biopharmaceutical firm plummeting $2.44 to $4.82.
posted by FC Market News at 9:09 AM
Wednesday, May 10, 2006
Previous Posts
- Teva Reports Loss
- Escala Group Embroiled In Stamp Scandal
- SanDisk Sells $1 Billion Notes
- Gold Prices Surge
- GM Upgraded
- Class Action Lawsuit Announced Against UnitedHealth
- Glenayre Reports Loss
- United Industrial Disappoints
- Entercom Beats Expectations
- Wheeling-Pittsburg May Enter Alliance With Companh...
0 Comments:
Post a Comment
<< Home